RADICAVA
RADICAVA
Approved
DIN Number
02532611
Drug Class
Human
Market Date
Feb 9, 2023
Company
HC
MITSUBISHI TANABE PHARMA CORPORATION
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02532611
AIG Number0160190002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N07XX14 EDARAVONE
Product Specifications
Dosage FormSuspension
Route of AdministrationOral
AHFS Classification28:44.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
EDARAVONEActive
Strength: 105 MG / 5 ML
Monograph: EDARAVONE